Skip to main content
. 2008 Oct 14;8:296. doi: 10.1186/1471-2407-8-296

Table 1.

Baseline clinical characteristics relative to surgical extent and tumor multifocality

Baseline characteristics Surgical extent Tumor multifocality Overall

Total or near-total (n = 173) Hemi- or subtotal (n = 134) P valuea Multifocal (n = 98) Solitary (n = 209) P valuea
Age at operation (> 45 yrs) 95 (55) 54 (40) 0.01 53 (54) 96 (46) 0.22 149 (49)
Gender (male) 16 (9) 16 (12) 0.46 9 (9) 23 (11) 0.69 32 (10)
Tumor size
 ≤ 0.5 cm 29 (17) 20 (15) 0.07 9 (9) 40 (19) 0.04 49 (16)
 > 0.5 cm and ≤ 0.8 cm 63 (36) 66 (49) 40 (41) 89 (43) 129 (42)
 > 0.8 cm 81 (47) 48 (36) 49 (50) 80 (38) 129 (42)
Multifocal tumor 84 (49) 14 (10) < .001 N/A N/A N/A 98 (32)
Bilateral tumor 57 (33) N/A 57 (69) N/A N/A 57 (19)
Extrathyroid extension 77 (45) 39 (29) 0.006 47 (48) 69 (33) 0.02 116 (38)
Lymph node metastasis
 pNx 17 (10) 27 (20) < 0.001 13 (13) 31 (15) 0.03 44 (14)
 pN0 64 (37) 60 (45) 30 (31) 94 (45) 124 (40)
 pN1ab 68 (39) 47 (35) 43 (44) 72 (34) 115 (37)
 pN1bc 24 (14) 0 12 (12) 12 (6) 24 (8)
Remnant ablation 163 (94) N/A 81 (83) 82 (39) < .001 163 (53)
Total or near-total thyroidectomy N/A N/A 84 (86) 89 (43) < .001 173 (56)

a by Fisher's exact test except for tumor size and lymph node metastasis; by the chi-squared test for tumor size and lymph node metastasis.

b Metastasis to level VI lymph nodes (pretracheal, paratracheal, and prelaryngeal/Delphian), classified as N1a in the 2002 TNM staging.

c Metastasis to unilateral, bilateral, or contralateral cervical superior mediastinal lymph nodes, classified as N1b in the 2002 TNM staging.

Percentages are given in parentheses; N/A, not applicable.